|
⚲
|
| Keyboard |
| Matrix Capital Management Company LP
✚
|
|
|---|---|
| CRD # | 160066 |
| SEC # | 801-73612 |
| CIK # | 0001410830, 0001906866 |
| AUM | 2.3 B (2026-03-31) |
| Employees | 7 (57% Investors, 0% Brokers) |
| Phone | 603-956-9151 |
| Address | 3 Pleasant Street Portsmouth, NH 03801 |
| Source | [IAPD] [EDGAR] [Website] [LinkedIn] |
| Total AUM ($B) |
|---|
| Sector | Form 13F Holdings | Value ($B) | |
|---|---|---|---|
| AURA Biosciences Inc | 0.0 | ||
| Holdings by Sector ($B) |
|---|
| Type | Form D Funds | Date | Sold | AUM |
|---|---|---|---|---|
| PE | Ayurmaya Capital Management Fund LP | [2021-12-15] | 655.0 M | 756.9 M |
| HF | Matrix Capital Management Fund II LP | [2012-02-14] | 24.7 M | 46.9 M |
| HF | Matrix Capital Management Master Fund LP | [2012-02-14] | 269.0 M | 1.6 B |
| HF | Matrix Capital Management Restricted Investment Fund LP | 2012-02-14 | 10.4 M |
| AUM Breakdown | Accounts | AUM ($B) |
|---|---|---|
| By Client Type | ||
| (a) Individuals (other than high net worth individuals) | 0 | 0.0 |
| (b) Individuals (high net worth individuals) | 0 | 0.0 |
| (c) Banking or thrift institutions | 0 | 0.0 |
| (d) Investment companies | 0 | 0.0 |
| (e) Business development companies | 0 | 0.0 |
| (f) Pooled investment vehicles | 4 | 2.3 |
| (g) Pension and profit sharing plans | 0 | 0.0 |
| (h) Charitable organizations | 0 | 0.0 |
| (i) State or municipal government entities | 0 | 0.0 |
| (j) Other investment advisers | 0 | 0.0 |
| (k) Insurance companies | 0 | 0.0 |
| (l) Sovereign wealth funds and foreign official institutions | 0 | 0.0 |
| (m) Corporations or other businesses not listed above | 0 | 0.0 |
| (n) Other | 0 | 0.0 |
| Total | 4 | 2.3 |
| By Discretionary | ||
| Discretionary | 4 | 2.3 |
| Non-Discretionary | 0 | 0.0 |
| Total | 4 | 2.3 |
| By Non-United States Persons | ||
| Non-United States Persons | 0.6 | |
| United States Persons | 1.7 | |
| Total | 4 | 2.3 |
| Form D Directors | Role | # Filings | # Firms | 2011 - 2026 |
|---|---|---|---|---|
| Laren Gillespie | 119 | 24 | ||
| Lisa Alexander | 75 | 17 | ||
| Richard Ruffer | 418 | 16 | ||
| Christine Fletcher | 70 | 14 | ||
| Alison Martinson | 38 | 13 | ||
| Gregory Brown | 30 | 3 | ||
| David Goel | 13 | 2 | ||
| Matrix General Partner LP | 2 | 2 | ||
| Matrix General Partner LLC | 2 | 2 | ||
| Ayurmaya General Partner LLC | 1 | 1 | ||
| View All | ||||
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 13F-HR | [0001410830] | |
| 3 | [0001410830] | |
| 4 | [0001410830] | |
| SC 13D | [0001410830] | |
| SC 13G | [0001410830] | |
| 13F-HR | [0001906866] |
| Firm Profile (Form ADV) | |
|---|---|
| Discretionary AUM | $1.5B |
| Serves | Institutional |
| Fund Types | Hedge Fund, Private Equity |
| LEI | 549300CAYJ90YENRRB21 |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Matrix Capital Management Company, LP | |
| Aura Biosciences, Inc. | |
| GOEL David E | |
| Zentalis Pharmaceuticals, Inc. | |
| Adaptive Biotechnologies Corp |
| Comparable Firms | State | AUM |
|---|---|---|
|
Oxford Finance Advisors LLC
✚
|
VA | 2.4 B |
|
Irenic Capital Management LP
✚
|
NY | 2.4 B |
|
Broadriver Asset Management LP
✚
|
NY | 2.3 B |
|
Tiptree Advisors LLC
✚
|
NY | 2.3 B |
|
SageView Capital LP
✚
|
CT | 2.3 B |
|
Varadero Capital LP
✚
|
NY | 2.3 B |
|
Waratah Capital Advisors Ltd
✚
|
2.3 B | |
|
Coliseum Capital Management LLC
✚
|
CT | 2.3 B |
|
Teng Yue Partners LP
✚
|
NY | 2.2 B |
|
Mason Capital Management LLC
✚
|
NY | 2.2 B |